Amyris drops 11%, announces capital structure transformation

Like
Comment
Favorite

Amyris drops 11%, announces capital structure transformation

seekingalpha2023-06-05

Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Yeahyeah
·2023-06-05
oh shiat.
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2341027060?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-06-05 22:20","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2341027060","market":"us","top_or_hot":-1,"title":"Amyris drops 11%, announces capital structure transformation","media":"seekingalpha","content":"<div>\n<p>Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity. ...</p>\n\n<a href=\"https://seekingalpha.com/news/3977587-amyris-drops-11-announces-capital-structure-transformation\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amyris drops 11%, announces capital structure transformation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmyris drops 11%, announces capital structure transformation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-06-05 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3977587-amyris-drops-11-announces-capital-structure-transformation><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity. ...</p>\n\n<a href=\"https://seekingalpha.com/news/3977587-amyris-drops-11-announces-capital-structure-transformation\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4109","symbol_name":"特种化学制品","start_time":0,"source_url":"https://seekingalpha.com/news/3977587-amyris-drops-11-announces-capital-structure-transformation","article_id":"2341027060","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2341027060","pubTimestamp":1685974854,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transform","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4109":"特种化学制品","AMRS":"阿米瑞斯"},"translate_title":"Amyris股价下跌11%，宣布资本结构转型","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMRS":1},"content_text":"Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity. The company has a cost reduction target of ~$250M from cost of goods sold, operating expense, including a reduction in force, and a simplification of its business portfolio.  On June 5, 2023, the company entered into a secured term loan facility with Anesma Group, an affiliate of Foris, whereby Anesma made available to the company up to $50M, which was partially drawn by the company on June 5, 2023. The company intends to use the net proceeds of funds advanced under the loan facility for working capital and general corporate purposes. The stock is down 11% on Monday.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":184130725302312,"gmtCreate":1685977446157,"gmtModify":1685978223800,"author":{"id":"3557827170519828","authorId":"3557827170519828","name":"Yeahyeah","avatar":"https://static.tigerbbs.com/ae58041562aacafaee66032c44c8dc37","vip":1,"crmLevel":4,"crmLevelSwitch":1},"htmlText":"oh shiat.","listText":"oh shiat.","text":"oh shiat.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184130725302312","repostId":2341027060,"repostType":2,"repost":{"id":"2341027060","pubTimestamp":1685974854,"share":"https://www.laohu8.com/m/news/2341027060?lang=&edition=full","pubTime":"2023-06-05 22:20","market":"us","language":"en","title":"Amyris drops 11%, announces capital structure transformation","url":"https://stock-news.laohu8.com/highlight/detail?id=2341027060","media":"seekingalpha","summary":"Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transform","content":"<html><body><ul> <li>Synthetic biotechnology company, Amyris (<span>NASDAQ:AMRS</span>) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity.</li> <li>The company has a cost reduction target of ~$250M from cost of goods sold, operating expense, including a<span> reduction in force, and a simplification of its business portfolio.</span> </li> <li>On June 5, 2023, the company entered into a secured term loan facility with Anesma Group, an affiliate of Foris, whereby Anesma made available to the company up to $50M, which was partially drawn by the company on June 5, 2023.</li> <li>The company intends to use the net proceeds of funds advanced under the loan facility for working capital and general corporate purposes.</li> <li>The stock is <span>down 11%</span> on Monday.</li> </ul></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amyris drops 11%, announces capital structure transformation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmyris drops 11%, announces capital structure transformation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-06-05 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3977587-amyris-drops-11-announces-capital-structure-transformation><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity. ...</p>\n\n<a href=\"https://seekingalpha.com/news/3977587-amyris-drops-11-announces-capital-structure-transformation\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMRS":"阿米瑞斯","BK4109":"特种化学制品"},"source_url":"https://seekingalpha.com/news/3977587-amyris-drops-11-announces-capital-structure-transformation","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2341027060","content_text":"Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity. The company has a cost reduction target of ~$250M from cost of goods sold, operating expense, including a reduction in force, and a simplification of its business portfolio.  On June 5, 2023, the company entered into a secured term loan facility with Anesma Group, an affiliate of Foris, whereby Anesma made available to the company up to $50M, which was partially drawn by the company on June 5, 2023. The company intends to use the net proceeds of funds advanced under the loan facility for working capital and general corporate purposes. The stock is down 11% on Monday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}